IL135108A0 - Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors - Google Patents

Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors

Info

Publication number: IL135108A0
Authority: IL; Israel
Prior art keywords: alkyl; alkoxy; cycloalkylalkyl; cycloalkyl; alkynoxy
Prior art date: 1997-10-27

Application number

IL13510898A

Other languages

English (en)

Original Assignee

Neurosearch As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-27

Filing date

1998-10-27

Publication date

2001-05-20

1998-10-27 Application filed by Neurosearch As filed Critical Neurosearch As

2001-05-20 Publication of IL135108A0 publication Critical patent/IL135108A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/22—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing two or more pyridine rings directly linked together, e.g. bipyridyl
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Pulmonology (AREA)
Psychology (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Cardiology (AREA)
Addiction (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyridine Compounds (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

IL13510898A 1997-10-27 1998-10-27 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors IL135108A0 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
DK122597		1997-10-27
DK40998		1998-03-24
DK79698		1998-06-19
PCT/DK1998/000465 WO1999021834A1 (en)	1997-10-27	1998-10-27	Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors

Publications (1)

Publication Number	Publication Date
IL135108A0 true IL135108A0 (en)	2001-05-20

Family

ID=27220661

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL13510898A IL135108A0 (en)	1997-10-27	1998-10-27	Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
IL135108A IL135108A (en)	1997-10-27	2000-03-16	History of homeopheresis, pharmaceutical preparations containing them and their use in the preparation of drugs for the treatment of diseases of the central or peripheral nervous system

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL135108A IL135108A (en)	1997-10-27	2000-03-16	History of homeopheresis, pharmaceutical preparations containing them and their use in the preparation of drugs for the treatment of diseases of the central or peripheral nervous system

Country Status (25)

Country	Link
US (2)	US6825189B1 (is)
EP (2)	EP1491532B1 (is)
JP (1)	JP4570773B2 (is)
KR (1)	KR100607838B1 (is)
CN (1)	CN1131211C (is)
AT (2)	ATE491689T1 (is)
AU (1)	AU744539B2 (is)
BR (1)	BR9813279B1 (is)
CA (1)	CA2306093C (is)
CZ (1)	CZ299499B6 (is)
DE (2)	DE69842058D1 (is)
DK (1)	DK1027336T3 (is)
EE (1)	EE04588B1 (is)
ES (1)	ES2230723T3 (is)
HU (1)	HU226859B1 (is)
IL (2)	IL135108A0 (is)
IS (1)	IS5420A (is)
NO (1)	NO317094B1 (is)
NZ (1)	NZ503520A (is)
PL (1)	PL203140B1 (is)
PT (1)	PT1027336E (is)
RU (1)	RU2205179C2 (is)
SK (1)	SK285198B6 (is)
TR (1)	TR200001171T2 (is)
WO (1)	WO1999021834A1 (is)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7214686B2 (en)	1997-06-30	2007-05-08	Targacept, Inc.	Pharmaceutical compositions and methods for effecting dopamine release
PT1027336E (pt) *	1997-10-27	2005-01-31	Neurosearch As	Heteroarildiazacicloalcanos como ligandos colinergicos de receptores nocotinicos de acetilcolina
WO2000064885A1 (en) *	1999-04-26	2000-11-02	Neurosearch A/S	Heteroaryl diazacycloalkanes, their preparation and use
EP1177196B1 (en) *	1999-05-04	2004-03-10	Neurosearch A/S	Heteroaryl diazabicycloalkanes, their preparation and use
GB9914026D0 (en) *	1999-06-17	1999-08-18	Zeneca Ltd	Chemical compounds
CA2389553C (en) *	1999-12-14	2010-06-22	Neurosearch A/S	Heteroaryl-diazabicycloalkanes
US6809105B2 (en)	2000-04-27	2004-10-26	Abbott Laboratories	Diazabicyclic central nervous system active agents
MY137020A (en) *	2000-04-27	2008-12-31	Abbott Lab	Diazabicyclic central nervous system active agents
WO2002030405A2 (en) *	2000-10-13	2002-04-18	Neurosearch A/S	Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
CA2341952A1 (en)	2001-03-23	2002-09-23	Universite Laval	Nicotinic receptor agonists for the treatment of inflammatory pulmonary diseases
US8039459B2 (en)	2004-07-15	2011-10-18	Universite Laval	Nicotinic receptor agonists for the treatment of inflammatory diseases
US8557804B2 (en)	2002-03-25	2013-10-15	Universite Laval	Nicotinic receptor agonists for the treatment of inflammatory diseases
EP1519939B9 (en)	2002-07-05	2011-04-06	Targacept, Inc.	N-aryl diazaspirocyclic compounds and methods of preparation and use thereof
AU2003254016A1 (en)	2002-07-19	2004-02-09	Catholic Healthcare West	Methods and compositions relating to chimeric nicotinic receptor subunits
US7098331B2 (en)	2003-03-05	2006-08-29	Targacept, Inc.	Arylvinylazacycloalkane compounds and methods of preparation and use thereof
GB0316915D0 (en)	2003-07-18	2003-08-20	Glaxo Group Ltd	Compounds
CA2539811A1 (en)	2003-10-15	2005-04-28	Targacept, Inc.	Azabicycyclic compounds for relieving pain and treating central nervous system disorders
EP1802258A4 (en)	2004-09-13	2015-09-23	Chrono Therapeutics Inc	BIOSYNCHRONE TRANSDERMAL MEDICINES
CA2580855A1 (en)	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
CN101044134A (zh)	2004-09-20	2007-09-26	塔加西普特公司	具有烟碱性胆碱能受体活性的氮杂螺烯和氮杂螺烷化合物
CA2580860A1 (en) *	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Pyridine derivatives for inhibiting human stearoyl-coa-desaturase
EP1799667B1 (en)	2004-09-20	2013-03-20	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as therapeutic agents
CA2580845A1 (en)	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
CA2580856A1 (en)	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
EP1804799B1 (en)	2004-09-20	2013-08-21	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
CN101084212A (zh)	2004-09-20	2007-12-05	泽农医药公司	杂环衍生物及其作为硬脂酰CoA去饱和酶介导剂的用途
EP1830837B1 (en)	2004-09-20	2013-09-04	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
US7459469B2 (en)	2004-11-10	2008-12-02	Targacept, Inc.	Hydroxybenzoate salts of metanicotine compounds
UA88792C2 (ru)	2004-11-10	2009-11-25	Таргасепт, Інк.	Гидроксибензоатные соли метаникотиновых соединений
MX2007008279A (es) *	2005-01-25	2008-02-15	Epix Delaware Inc	Compuestos de arilamina sustituidos y su uso como moduladores de la 5-ht6.
FR2885615B1 (fr) *	2005-05-12	2007-06-22	Servier Lab	Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2885616B1 (fr) *	2005-05-12	2007-06-22	Servier Lab	Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MX2007015216A (es)	2005-06-03	2008-02-22	Xenon Pharmaceuticals Inc	Derivados de aminotiazol y sus usos como agentes terapeuticos.
FR2889188B1 (fr) *	2005-07-28	2007-09-07	Servier Lab	Nouveaux composes 1,1-pyridinylaminocyclopropanamines polysubstitues, leur procede de preparation et les compositions phamaceutiques qui les contiennent
CN101248073A (zh)	2005-08-22	2008-08-20	塔加西普特公司	杂芳基-取代的二氮杂三环烷类、其制备方法及其应用
US20070134169A1 (en) *	2005-12-11	2007-06-14	Rabinoff Michael D	Methods for smoking cessation or alcohol cessation or other addiction cessation
TWI389889B (zh)	2006-05-09	2013-03-21	Targacept Inc	（２ｓ）-（４ｅ）-ｎ-甲基-５-〔３-（５-異丙氧基吡啶）基〕-４-戊烯-２-胺之新穎多晶型
JP2009536665A (ja)	2006-05-09	2009-10-15	アストラゼネカ・アクチエボラーグ	（２ｓ）−（４ｅ）−ｎ−メチル−５−［３−（５−イソプロポキシピリジン）イル］−４−ペンテン−２−アミンの新規な塩形態
MX2008014532A (es)	2006-05-30	2008-11-27	Hoffmann La Roche	Derivados de piperidinil pirimidinas.
US20100234349A1 (en)	2006-09-04	2010-09-16	Olsen Gunnar M	Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer
ES2521494T3 (es)	2007-04-02	2014-11-12	Parkinson's Institute	Métodos y composiciones para la reducción de los efectos secundarios de tratamientos terapéuticos
JP5603770B2 (ja) *	2007-05-31	2014-10-08	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Ｃｃｒ２受容体拮抗薬およびその使用
ES2362326T3 (es)	2007-10-01	2011-07-01	Comentis, Inc.	Derivados de 1h-indol-3-carboxilato de quinuclidin-4-ilmetilo como ligandos del receptor nicotínico alfa 7 de la acetilcolina para el tratamiento de enfermedad de alzheimer.
US8697722B2 (en) *	2007-11-02	2014-04-15	Sri International	Nicotinic acetylcholine receptor modulators
EA020548B1 (ru)	2008-12-19	2014-12-30	Бёрингер Ингельхайм Интернациональ Гмбх	Циклические пиримидин-4-карбоксамиды в качестве антагонистов рецептора ccr2, предназначенные для лечения воспаления, астмы и хозл
PE20121556A1 (es)	2009-12-07	2012-12-05	Targacept Inc	3,6-diazabiciclo[3.1.1]heptanos como ligandos de receptores nicotinicos neuronales de acetilcolina
PE20121614A1 (es)	2009-12-17	2012-12-21	Boehringer Ingelheim Int	Derivados de 6-amino,4-carbonil-pirimidina sustituida como antagonistas del receptor ccr2
US9062042B2 (en) *	2010-01-11	2015-06-23	Astraea Therapeutics, Llc	Nicotinic acetylcholine receptor modulators
MX2012008550A (es)	2010-02-05	2012-09-07	Merck Patent Gmbh	Derivados de hetaril-[1, 8]naftiridina.
EP2377860A1 (en) *	2010-04-16	2011-10-19	AC Immune S.A.	Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
JP5646736B2 (ja)	2010-05-12	2014-12-24	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	新規ｃｃｒ２受容体アンタゴニスト、これらの製造方法、及び薬物としてのこれらの使用
EP2569298B1 (en)	2010-05-12	2015-11-25	Boehringer Ingelheim International GmbH	Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
WO2011144501A1 (en)	2010-05-17	2011-11-24	Boehringer Ingelheim International Gmbh	Ccr2 antagonists and uses thereof
WO2011146009A1 (en)	2010-05-20	2011-11-24	Targacept Inc.	New process for the preparation of aryl substituted olefinic amines
WO2011147772A1 (en)	2010-05-25	2011-12-01	Boehringer Ingelheim International Gmbh	Ccr2 receptor antagonists
EP2576538B1 (en)	2010-06-01	2015-10-28	Boehringer Ingelheim International GmbH	New CCR2 antagonists
EP2671901A4 (en) *	2011-02-01	2018-01-17	Industrial Cooperation Foundation Chonbuk National	Biodegradable paox microspheres having cationic properties
JP5786258B2 (ja)	2011-07-15	2015-09-30	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	新規かつ選択的なｃｃｒ２拮抗薬
CN102924390B (zh) *	2012-09-07	2014-12-31	苏州康润医药有限公司	1,5-二氮杂环辛烷-1-甲酸叔丁酯的合成方法
US20170166561A1 (en)	2014-07-11	2017-06-15	Alpharmagen, Llc	Quinuclidine compounds for modulating alpha7-nicotinic acetylcholine receptor activity
JP2018511355A (ja)	2015-01-28	2018-04-26	クロノセラピューティクスインコーポレイテッドＣｈｒｏｎｏＴｈｅｒａｐｅｕｔｉｃｓＩｎｃ．	薬剤送達方法及びシステム
CA2990460C (en)	2015-07-02	2023-10-17	Centrexion Therapeutics Corporation	(4-((3r,4r)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-yl)(5-methyl-6-(((2r,6s)-6-(p-tolyl)tetrahydro-2h-pyran-2-yl)methylamino)pyrimidin-4-yl)methanone citrate
JP2020503950A (ja)	2017-01-06	2020-02-06	クロノセラピューティクスインコーポレイテッドＣｈｒｏｎｏＴｈｅｒａｐｅｕｔｉｃｓＩｎｃ．	経皮薬剤送達の装置及び方法
US11596779B2 (en)	2018-05-29	2023-03-07	Morningside Venture Investments Limited	Drug delivery methods and systems
CA3119992A1 (en)	2018-11-16	2020-05-22	Morningside Venture Investments Limited	Thermally regulated transdermal drug delivery system

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2985657A (en) *	1959-10-12	1961-05-23	Paul A J Janssen	1-(aroylalkyl)-4-heterocyclylpiperazines
JPS4966691A (is) *	1972-10-30	1974-06-27
US4017622A (en)	1972-12-18	1977-04-12	Dainippon Pharmaceutical Co., Ltd.	Piperazine derivatives
AT330777B (de)	1973-09-08	1976-07-26	Thomae Gmbh Dr K	Verfahren zur herstellung von neuen isochinolinderivaten und deren salzen
EG12387A (en) *	1975-04-21	1978-12-31	Merck & Co Inc	Process for preparing of piperazinyl pyrazines
US3994898A (en) *	1975-10-16	1976-11-30	E. R. Squibb & Sons, Inc.	1,2,4-Triazolo (4,3-b) pyridazin-3-ones
NL171985C (nl) *	1976-02-10	1983-06-16	Rhone Poulenc Ind	Werkwijze voor het bereiden van preparaten met werking tegen schistosomiasis, de aldus verkregen gevormde preparaten en werkwijze voor het bereiden van 1,2-dithioolverbindingen.
GB1542030A (en) *	1976-08-19	1979-03-14	Sterling Drug Inc	Cyclic alkylidenyl n-(pyridazinyl)aminomethylenemalomates and their preparation
DE2708187A1 (de) *	1977-02-25	1978-08-31	Thomae Gmbh Dr K	Neue pyrido-pyridazin-one
HU176972B (hu) *	1977-06-13	1981-06-28	Gyogyszerkutato Intezet	Sposob poluchenija novykh proizvodnykh piridazinil-gidrazona
US4163849A (en) *	1978-03-17	1979-08-07	Merck & Co., Inc.	Piperazinylpyrazines
US4179563A (en) *	1978-05-19	1979-12-18	Warner-Lambert Company	3-Aryloxy-substituted-aminopyridines and methods for their production
JPS5618983A (en) *	1979-07-25	1981-02-23	Eisai Co Ltd	Theophylline derivative and its preapration
US4251530A (en)	1980-02-19	1981-02-17	Merck & Co., Inc.	2-{[4-(6-Substituted-2-pyrazinyl)-1-piperazinyl]alkyl}-5-substituted-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one analgesic agents
DE3034001A1 (de) *	1980-09-10	1982-04-22	Hoechst Ag, 6000 Frankfurt	Isochinolinderivate, verfahren zu ihrer hersellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung
FI70411C (fi) *	1980-12-29	1986-09-19	Pfizer	Foerfarande foer framstaellning av nya antihypertensiva 4-amino-6,7-dimetoxi-2-piperazinokinazolin derivat
JPS60226862A (ja) *	1984-03-26	1985-11-12	ジヤンセン・フア−マシユ−チカ・ナ−ムロ−ゼ・フエンノ−トシヤツプ	抗ウイルス活性ピリダジンアミン類
US5001125A (en) *	1984-03-26	1991-03-19	Janssen Pharmaceutica N.V.	Anti-virally active pyridazinamines
ES8802151A1 (es) *	1985-07-31	1988-04-01	Janssen Pharmaceutica Nv	Un procedimiento para la preparacion de nuevos piridazinaminas.
GB8603120D0 (en) *	1986-02-07	1986-03-12	Pfizer Ltd	Anti-dysrhythmia agents
GB8609630D0 (en) *	1986-04-19	1986-05-21	Pfizer Ltd	Anti-arrhythmia agents
SE8701375D0 (sv)	1987-04-02	1987-04-02	Leo Ab	Novel pyridyl- and pyrimidyl derivatives
MY104343A (en) *	1987-11-23	1994-03-31	Janssen Pharmaceutica Nv	Novel pyridizinamine deravatives
US4876256A (en)	1988-04-29	1989-10-24	Merck & Co., Inc.	Alkylpiperazinylpyridines as hypoglycemic agents
SE8803429D0 (sv)	1988-09-28	1988-09-28	Pharmacia Ab	Novel pyridyl- and pyrimidyl derivatives
JPH02167265A (ja) *	1988-09-30	1990-06-27	Chugai Pharmaceut Co Ltd	新規な３，４―ジアミノキノリン及びピリジン系化合物
EP0361489A3 (en) *	1988-09-30	1991-06-12	Chugai Seiyaku Kabushiki Kaisha	Novel 3,4-diaminoquinoline and pyridine compounds
IE62792B1 (en)	1988-11-24	1995-03-08	Akzo Nv	Pharmaceutical composition containing 1-(mono- or bis (Trifluoromethyl)-2-pyridinyl) piperazines
JP2843632B2 (ja) *	1989-03-01	1999-01-06	日清製粉株式会社	ピリジンカルボン酸アミド誘導体
US4994456A (en) *	1989-03-01	1991-02-19	Nisshin Flour Milling Co., Ltd.	Pyridinecarboxylic acid amide derivatives and pharmaceutical compositions comprising same
NZ233526A (en) *	1989-05-15	1991-09-25	Janssen Pharmaceutica Nv	Pyridazine derivatives and their pharmaceutical compositions
HK1002235A1 (en) *	1989-12-28	1998-08-07	Pharmacia & Upjohn Company	Diaromatic substituted anti-aids compounds
WO1993001181A1 (en) *	1991-07-03	1993-01-21	The Upjohn Company	Substituted indoles as anti-aids pharmaceuticals
JPH05345764A (ja) *	1991-11-26	1993-12-27	Asahi Chem Ind Co Ltd	新規アゼピン誘導体、その製造法およびその用途
SE9201239D0 (sv)	1992-04-21	1992-04-21	Kabi Pharmacia Ab	Agents for treating substance abuse disorders
TW279864B (is) *	1993-02-19	1996-07-01	Janssen Pharmaceutica Nv
EP0690713A4 (en) *	1993-03-17	1996-04-03	Abbott Lab	SUBSTITUTED MACROCYCLIC IMMUNOMODULATORS CONTAINING ALICYCLIC AMINES
GB9408185D0 (en) *	1994-04-25	1994-06-15	Fujisawa Pharmaceutical Co	New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
US5607936A (en) *	1994-09-30	1997-03-04	Merck & Co., Inc.	Substituted aryl piperazines as neurokinin antagonists
AU4420296A (en)	1994-11-23	1996-06-17	Neurogen Corporation	Aminomethyl aryl compounds; dopamine receptor subtype selective ligands
NZ326354A (en) *	1996-01-15	1999-05-28	Janssen Pharmaceutica Nv	3-(substituted-1-piperazinyl)-6-(substituted-1,2,4-thiadiazol-5 -yl)-pyridazine derivatives and medicaments
US5929281A (en) *	1996-04-19	1999-07-27	Tosoh Corporation	Process for producing heterocyclic aromatic amine or arylamine
SE9601708D0 (sv)	1996-05-06	1996-05-06	Pharmacia Ab	Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders
GB9614236D0 (en) *	1996-07-06	1996-09-04	Zeneca Ltd	Chemical compounds
JP3216566B2 (ja) *	1996-07-15	2001-10-09	東ソー株式会社	複素環式芳香族アミン類の製造方法
WO1998031679A1 (en) *	1997-01-21	1998-07-23	Yoshitomi Pharmaceutical Industries, Ltd.	Thiophene compounds and medicinal use thereof
DE19724980A1 (de) *	1997-06-13	1998-12-17	Basf Ag	3-Substituierte 3,4-Dihydro-thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung
KR20010022507A (ko) *	1997-08-15	2001-03-15	실버스타인 아써 에이.	도파민 디4 수용체와 상호작용하는 2-(4-아릴 또는헤테로아릴-피페라진-1-일메틸)-1수소-인돌 유도체
AU744577B2 (en) *	1997-10-14	2002-02-28	Mitsubishi Pharma Corporation	Piperazine compounds and medicinal use thereof
PT1027336E (pt) *	1997-10-27	2005-01-31	Neurosearch As	Heteroarildiazacicloalcanos como ligandos colinergicos de receptores nocotinicos de acetilcolina
GB9726736D0 (en)	1997-12-18	1998-02-18	Zeneca Ltd	Chemical compounds

1998
- 1998-10-27 PT PT98951286T patent/PT1027336E/pt unknown
- 1998-10-27 CZ CZ20001507A patent/CZ299499B6/cs not_active IP Right Cessation
- 1998-10-27 ES ES98951286T patent/ES2230723T3/es not_active Expired - Lifetime
- 1998-10-27 EP EP04102866A patent/EP1491532B1/en not_active Expired - Lifetime
- 1998-10-27 RU RU2000110744/04A patent/RU2205179C2/ru not_active IP Right Cessation
- 1998-10-27 DE DE69842058T patent/DE69842058D1/de not_active Expired - Lifetime
- 1998-10-27 AT AT04102866T patent/ATE491689T1/de not_active IP Right Cessation
- 1998-10-27 AU AU97368/98A patent/AU744539B2/en not_active Ceased
- 1998-10-27 WO PCT/DK1998/000465 patent/WO1999021834A1/en not_active Ceased
- 1998-10-27 EP EP98951286A patent/EP1027336B1/en not_active Expired - Lifetime
- 1998-10-27 EE EEP200000178A patent/EE04588B1/xx not_active IP Right Cessation
- 1998-10-27 NZ NZ503520A patent/NZ503520A/xx unknown
- 1998-10-27 BR BRPI9813279-2A patent/BR9813279B1/pt not_active IP Right Cessation
- 1998-10-27 AT AT98951286T patent/ATE278670T1/de active
- 1998-10-27 HU HU0100426A patent/HU226859B1/hu not_active IP Right Cessation
- 1998-10-27 KR KR1020007004495A patent/KR100607838B1/ko not_active Expired - Fee Related
- 1998-10-27 CN CN98810601A patent/CN1131211C/zh not_active Expired - Fee Related
- 1998-10-27 SK SK614-2000A patent/SK285198B6/sk not_active IP Right Cessation
- 1998-10-27 PL PL340224A patent/PL203140B1/pl not_active IP Right Cessation
- 1998-10-27 DE DE69826883T patent/DE69826883T2/de not_active Expired - Lifetime
- 1998-10-27 DK DK98951286T patent/DK1027336T3/da active
- 1998-10-27 TR TR2000/01171T patent/TR200001171T2/xx unknown
- 1998-10-27 JP JP2000517946A patent/JP4570773B2/ja not_active Expired - Fee Related
- 1998-10-27 CA CA2306093A patent/CA2306093C/en not_active Expired - Fee Related
- 1998-10-27 IL IL13510898A patent/IL135108A0/xx active IP Right Grant
2000
- 2000-03-16 IL IL135108A patent/IL135108A/en not_active IP Right Cessation
- 2000-03-17 US US09/528,176 patent/US6825189B1/en not_active Expired - Fee Related
- 2000-03-28 IS IS5420A patent/IS5420A/is unknown
- 2000-04-26 NO NO20002132A patent/NO317094B1/no not_active IP Right Cessation
2003
- 2003-10-03 US US10/677,240 patent/US6897219B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US6825189B1 (en)	2004-11-30
PL203140B1 (pl)	2009-08-31
PL340224A1 (en)	2001-01-15
SK285198B6 (sk)	2006-08-03
BR9813279A (pt)	2000-08-22
RU2205179C2 (ru)	2003-05-27
WO1999021834A1 (en)	1999-05-06
JP2001521025A (ja)	2001-11-06
HU226859B1 (en)	2009-12-28
AU9736898A (en)	1999-05-17
EP1027336B1 (en)	2004-10-06
ES2230723T3 (es)	2005-05-01
SK6142000A3 (en)	2000-09-12
HUP0100426A3 (en)	2002-03-28
DK1027336T3 (da)	2005-01-24
KR100607838B1 (ko)	2006-08-04
PT1027336E (pt)	2005-01-31
CN1277604A (zh)	2000-12-20
BR9813279B1 (pt)	2010-11-16
IL135108A (en)	2006-12-31
ATE278670T1 (de)	2004-10-15
CA2306093C (en)	2011-01-04
NO317094B1 (no)	2004-08-09
NO20002132L (no)	2000-04-26
HK1031378A1 (en)	2001-06-15
DE69826883D1 (de)	2004-11-11
IS5420A (is)	2000-03-28
HUP0100426A2 (hu)	2002-02-28
AU744539B2 (en)	2002-02-28
CN1131211C (zh)	2003-12-17
TR200001171T2 (tr)	2000-10-23
NZ503520A (en)	2002-08-28
KR20010031461A (ko)	2001-04-16
CA2306093A1 (en)	1999-05-06
DE69842058D1 (de)	2011-01-27
EE200000178A (et)	2001-04-16
EP1491532B1 (en)	2010-12-15
US20040072823A1 (en)	2004-04-15
ATE491689T1 (de)	2011-01-15
JP4570773B2 (ja)	2010-10-27
EP1491532A1 (en)	2004-12-29
US6897219B2 (en)	2005-05-24
EP1027336A1 (en)	2000-08-16
CZ20001507A3 (cs)	2000-08-16
DE69826883T2 (de)	2005-02-03
NO20002132D0 (no)	2000-04-26
CZ299499B6 (cs)	2008-08-13
EE04588B1 (et)	2006-02-15

Publication	Publication Date	Title
IL135108A0 (en)	2001-05-20	Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
ATE390404T1 (de)	2008-04-15	Aminderivate, ihre herstellung und verwendung als inhibitoren der produktion von amyloid-beta
TR199801594A2 (xx)	1999-03-22	CCR-3 resept�r antagonistleri.
HUP9802036A3 (en)	1999-06-28	Novel substituted piperazine derivatives having tachykinin receptor antagonists activity, process for producing them an pharmaceutical compositions containing them
IL119729A0 (en)	1997-03-18	Heterocyclic compounds having tachykinin receptor antagonist activity pharmaceutical compositions containing the same and processes for the preparation thereof
ATE212978T1 (de)	2002-02-15	Para-substituierte phenylpropansäure derivate als integrin-antagonisten
IL180654A0 (en)	2007-06-03	Substituted oxindol derivatives and medicaments containing the same
DE69528257D1 (de)	2002-10-24	KONDENSIERTE HETEROCYCLISCHE VERBINDUNG, DEREN HERSTELLUNG UND VERWENDUNG ALS GnRH ANTAGONISTEN
RU2005101088A (ru)	2005-06-27	Катионозамещенные дифенилазетидиноны, способ их получения, лекарственные средства, содержащие эти соединения, и их применение
BG102715A (bg)	1999-08-31	Нови производни на арилглицинамид, метод за получаването им и фармацевтични състави съдържащи, ги
YU53100A (sh)	2003-04-30	Derivati 2-ariletil-(piperidin-4-ilmetil)amina kao antagonisti muskarinskih receptora
ATE254618T1 (de)	2003-12-15	Spiro chinuclidin-derivate, ihre herstellung und verwendung
CA2187309A1 (en)	1995-10-26	Tropane-2-aldoxime derivatives as neurotransmitter reuptake inhibitors
ATE220399T1 (de)	2002-07-15	Neue naphthamid-derivate und ihre therapeutische verwendung als d3-rezeptor agonisten
FI963440A0 (fi)	1996-09-03	Uudet aminohappojohdannaiset, näiden valmistusmenetelmä ja näitä yhdisteitä sisältävät farmaseuttiset seokset
DE69637941D1 (de)	2009-07-09	Modifizierte hämoglobinähnliche verbindungen und verfahren zu deren reinigung
PL321545A1 (en)	1997-12-08	Substituted phenyl compounds and method of applying them as endoteline antagonists
ES2104688T3 (es)	1997-10-16	Un procedimiento para la preparacion de un compuesto de tio-3-cefem 3-sustituido.
PL323339A1 (en)	1998-06-08	Novel benzopyranic compounds, method of obtaining them and pharmaceutic compositions containing such compounds
EE200000024A (et)	2000-10-16	Meetod alküüloksüfuranooni amiinderivaatide valmistamiseks, sel meetodil saadud ühendid ja nende kasutamine
FR2777780B1 (fr)	2001-05-04	Derives d'(alpha-aminophosphino) peptides, leur procede de preparation et les compositions qui les contiennent
TR200001976T2 (tr)	2000-11-21	İzopropil-Metil [2-(3-n-propoksifenoksi)etil] amin'in hazırlanmasına yönelik usul
LTIP1718A (en)	1995-07-25	New heterocyclic compounds as antagonists of exitatory amino acids receptors, process for their preparation and their use
ATE245155T1 (de)	2003-08-15	N-substituierte 1-(butyrolacton)-isochinoline zur behandlung von nervenstörungen
MY118101A (en)	2004-08-30	New 17-halogeno-19-nor-steroids, a process and intermediates for their preparation, their use as medicaments and pharmaceutical compositions comprising them

Legal Events

Date	Code	Title
2007-07-06	FF	Patent granted
2007-07-06	KB	Patent renewed
2009-05-03	FF	Patent granted